vs

Side-by-side financial comparison of CABOT CORP (CBT) and MERCURY GENERAL CORP (MCY). Click either name above to swap in a different company.

MERCURY GENERAL CORP is the larger business by last-quarter revenue ($1.5B vs $849.0M, roughly 1.8× CABOT CORP). MERCURY GENERAL CORP runs the higher net margin — 12.4% vs 8.6%, a 3.8% gap on every dollar of revenue. On growth, MERCURY GENERAL CORP posted the faster year-over-year revenue change (10.5% vs -11.1%). Over the past eight quarters, MERCURY GENERAL CORP's revenue compounded faster (8.6% CAGR vs -8.7%).

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

Mercury General Corporation is a multiple-line insurance organization that offers personal automobiles, homeowners, renters, and business insurance. Mercury's primary focus is automobiles and homeowners' insurance.

CBT vs MCY — Head-to-Head

Bigger by revenue
MCY
MCY
1.8× larger
MCY
$1.5B
$849.0M
CBT
Growing faster (revenue YoY)
MCY
MCY
+21.6% gap
MCY
10.5%
-11.1%
CBT
Higher net margin
MCY
MCY
3.8% more per $
MCY
12.4%
8.6%
CBT
Faster 2-yr revenue CAGR
MCY
MCY
Annualised
MCY
8.6%
-8.7%
CBT

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CBT
CBT
MCY
MCY
Revenue
$849.0M
$1.5B
Net Profit
$73.0M
$190.4M
Gross Margin
24.9%
Operating Margin
15.2%
Net Margin
8.6%
12.4%
Revenue YoY
-11.1%
10.5%
Net Profit YoY
-21.5%
-36.3%
EPS (diluted)
$1.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBT
CBT
MCY
MCY
Q1 26
$1.5B
Q4 25
$849.0M
$1.5B
Q3 25
$899.0M
$1.6B
Q2 25
$923.0M
$1.5B
Q1 25
$936.0M
$1.4B
Q4 24
$955.0M
$1.4B
Q3 24
$1.0B
$1.5B
Q2 24
$1.0B
$1.3B
Net Profit
CBT
CBT
MCY
MCY
Q1 26
$190.4M
Q4 25
$73.0M
$202.5M
Q3 25
$43.0M
$280.4M
Q2 25
$101.0M
$166.5M
Q1 25
$94.0M
$-108.3M
Q4 24
$93.0M
$101.1M
Q3 24
$137.0M
$230.9M
Q2 24
$109.0M
$62.6M
Gross Margin
CBT
CBT
MCY
MCY
Q1 26
Q4 25
24.9%
99.7%
Q3 25
24.5%
99.8%
Q2 25
26.4%
99.8%
Q1 25
25.7%
99.7%
Q4 24
24.6%
99.7%
Q3 24
24.0%
99.8%
Q2 24
25.2%
99.8%
Operating Margin
CBT
CBT
MCY
MCY
Q1 26
Q4 25
15.2%
16.2%
Q3 25
15.2%
22.1%
Q2 25
18.1%
14.0%
Q1 25
17.3%
-10.2%
Q4 24
16.2%
9.0%
Q3 24
15.0%
18.8%
Q2 24
16.9%
5.8%
Net Margin
CBT
CBT
MCY
MCY
Q1 26
12.4%
Q4 25
8.6%
13.2%
Q3 25
4.8%
17.7%
Q2 25
10.9%
11.3%
Q1 25
10.0%
-7.8%
Q4 24
9.7%
7.4%
Q3 24
13.7%
15.1%
Q2 24
10.7%
4.8%
EPS (diluted)
CBT
CBT
MCY
MCY
Q1 26
Q4 25
$1.37
$3.66
Q3 25
$0.80
$5.06
Q2 25
$1.86
$3.01
Q1 25
$1.69
$-1.96
Q4 24
$1.67
$1.82
Q3 24
$2.41
$4.17
Q2 24
$1.94
$1.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBT
CBT
MCY
MCY
Cash + ST InvestmentsLiquidity on hand
$230.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.6B
$2.6B
Total Assets
$3.8B
$9.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBT
CBT
MCY
MCY
Q1 26
Q4 25
$230.0M
Q3 25
$258.0M
Q2 25
$239.0M
Q1 25
$213.0M
Q4 24
$183.0M
Q3 24
$223.0M
Q2 24
$197.0M
Total Debt
CBT
CBT
MCY
MCY
Q1 26
Q4 25
$575.0M
Q3 25
$1.1B
Q2 25
Q1 25
Q4 24
$575.0M
Q3 24
$1.1B
Q2 24
Stockholders' Equity
CBT
CBT
MCY
MCY
Q1 26
$2.6B
Q4 25
$1.6B
$2.4B
Q3 25
$1.6B
$2.2B
Q2 25
$1.5B
$2.0B
Q1 25
$1.4B
$1.8B
Q4 24
$1.4B
$1.9B
Q3 24
$1.4B
$1.9B
Q2 24
$1.3B
$1.6B
Total Assets
CBT
CBT
MCY
MCY
Q1 26
$9.9B
Q4 25
$3.8B
$9.6B
Q3 25
$3.8B
$9.4B
Q2 25
$3.8B
$9.1B
Q1 25
$3.8B
$9.0B
Q4 24
$3.6B
$8.3B
Q3 24
$3.7B
$8.2B
Q2 24
$3.6B
$7.7B
Debt / Equity
CBT
CBT
MCY
MCY
Q1 26
Q4 25
0.24×
Q3 25
0.70×
Q2 25
Q1 25
Q4 24
0.30×
Q3 24
0.75×
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBT
CBT
MCY
MCY
Operating Cash FlowLast quarter
$126.0M
Free Cash FlowOCF − Capex
$57.0M
FCF MarginFCF / Revenue
6.7%
Capex IntensityCapex / Revenue
8.1%
Cash ConversionOCF / Net Profit
1.73×
TTM Free Cash FlowTrailing 4 quarters
$401.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBT
CBT
MCY
MCY
Q1 26
Q4 25
$126.0M
$287.9M
Q3 25
$219.0M
$496.4M
Q2 25
$249.0M
$371.6M
Q1 25
$73.0M
$-68.7M
Q4 24
$124.0M
$248.3M
Q3 24
$204.0M
$318.1M
Q2 24
$207.0M
$278.0M
Free Cash Flow
CBT
CBT
MCY
MCY
Q1 26
Q4 25
$57.0M
$273.9M
Q3 25
$155.0M
$479.5M
Q2 25
$188.0M
$357.2M
Q1 25
$1.0M
$-81.9M
Q4 24
$47.0M
$236.0M
Q3 24
$112.0M
$306.2M
Q2 24
$155.0M
$266.5M
FCF Margin
CBT
CBT
MCY
MCY
Q1 26
Q4 25
6.7%
17.8%
Q3 25
17.2%
30.3%
Q2 25
20.4%
24.2%
Q1 25
0.1%
-5.9%
Q4 24
4.9%
17.3%
Q3 24
11.2%
20.0%
Q2 24
15.3%
20.4%
Capex Intensity
CBT
CBT
MCY
MCY
Q1 26
Q4 25
8.1%
0.9%
Q3 25
7.1%
1.1%
Q2 25
6.6%
1.0%
Q1 25
7.7%
0.9%
Q4 24
8.1%
0.9%
Q3 24
9.2%
0.8%
Q2 24
5.1%
0.9%
Cash Conversion
CBT
CBT
MCY
MCY
Q1 26
Q4 25
1.73×
1.42×
Q3 25
5.09×
1.77×
Q2 25
2.47×
2.23×
Q1 25
0.78×
Q4 24
1.33×
2.46×
Q3 24
1.49×
1.38×
Q2 24
1.90×
4.44×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

MCY
MCY

Segment breakdown not available.

Related Comparisons